Disposal of the robotics division to Softbank group for $5.4bn.

Confirmation of European quotas and tariffs on steel.

Change in Payout ratio is positive but could mark the peak in momentum.

Strategic acquisition in the US in equipment for Datacenters/AI.

Strong H1 results in a context of strong inflation.

X read following the Pfizer deal is actually positive for Pharmas.